Antibiotic Therapy

Brand Name Molecule ATC Category Packaging Class
Chimono Lomefloxacine Systemic antibacterials 5 tablets 400 mg A
Overal Roxithromycin Systemic antibacterials 12 tablets 150 mg A
12 delitescent tablets 50 mg A
6 tablets 300 mg A
Supracef Cefixime Systemic antibacterials 5 dispersible tablets 400 mg A
100 mg / 5 ml for oral suspension A

Our products

Lusofarmaco can claim extensive know-how in various therapeutic areas: cardiovascular and respiratory diseases, antibiotic therapy, neuropsychiatry and gynecology.

Research & Development

For many years, Lusofarmaco has been mainly a national company, with a portfolio focused on well-established medicinal products, which have been the reference drugs in their respective therapeutic areas.

Pharmacovigilance

The science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem.

Registered Office:
Milanofiori – Strada 6, Edificio L – 20089 Rozzano (MI)
Tel. 02-516555.1 - Fax 02-516555.249

Registration No. In Registrar Of Companies: 00714810157
Registrar Of Companies' Office: Milano
Registered Capital: € 130.000 I.V.
Capital Reported In Last Financial Statement: € 130.000
Company subject to the direction and coordination of A. Menarini Industrie Farmaceutiche Riunite Srl

SITEMAP

Copyright 2021 Istituto Lusofarmaco D'Italia S.p.A.